Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) had its target price raised by investment analysts at JPMorgan Chase & Co. from $8.00 to $15.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 6.53% from the stock’s current price.
AVAH has been the subject of a number of other reports. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Barclays raised their price objective on Aveanna Healthcare from $9.50 to $15.00 and gave the company an “overweight” rating in a research note on Friday, August 28th. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Raymond James Financial boosted their target price on Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research note on Friday, August 14th. Finally, Royal Bank Of Canada raised their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday, August 24th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $14.06.
Check Out Our Latest Research Report on AVAH
Aveanna Healthcare Stock Performance
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The firm had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. Research analysts forecast that Aveanna Healthcare will post 0.75 EPS for the current fiscal year.
Insider Transactions at Aveanna Healthcare
In other news, major shareholder Robert Williams, Jr. sold 14,500,002 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $166,750,023.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the firm’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $143,704,885.50. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 59,904,505 shares of company stock valued at $649,301,514. Corporate insiders own 5.30% of the company’s stock.
Hedge Funds Weigh In On Aveanna Healthcare
A number of hedge funds have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd grew its holdings in shares of Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after buying an additional 2,400 shares during the last quarter. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare during the 2nd quarter valued at $43,000. Summit Securities Group LLC bought a new stake in shares of Aveanna Healthcare in the 1st quarter worth $53,000. Oxford Asset Management LLP purchased a new position in shares of Aveanna Healthcare in the second quarter worth $64,000. Finally, C M Bidwell & Associates Ltd. bought a new position in shares of Aveanna Healthcare during the second quarter valued at $69,000. Institutional investors own 87.96% of the company’s stock.
About Aveanna Healthcare
Aveanna Healthcare Corporation is a provider of home-based healthcare services for children, adults and families in the United States. The company’s services are designed to help patients receive medical and supportive care in their homes and communities, including individuals with complex, chronic or medically fragile conditions.
Aveanna’s principal services include private-duty nursing, home health, hospice and personal care. It also provides pediatric therapy and related clinical services, including physical, occupational and speech therapy.
Read More
- Five stocks we like better than Aveanna Healthcare
- Blue-Chip Stocks Are Looking Anything But Boring With Dividends and Big 2026 Gains
- Digging for Value: Alpha Metallurgical Resources Insider Buys Big
- Smart Money Shifts: U.S. Bancorp Pairs Tech With Yield
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
